Improving coping skills benefits family caregivers of hospice patients with cancer

December 19, 2005

Caregivers of cancer patients dying at home significantly benefited from supportive educational sessions in which hospice nurses taught the caregivers how to cope with distressing patient symptoms, researchers at the University of South Florida report.

The study - one of the first randomized clinical trials conducted with caregivers of patients near the end of life - was funded by the National Cancer Institute and National Institute for Nursing Research. It was published online Dec. 2 in Cancer, the journal of the American Cancer Society, and will appear in January's printed issue.

As many as 52 million Americans assist family members with an illness or disability, including many who provide extensive care for relatives with cancer. Previous studies have shown highly stressed family caregivers are at higher risk for depression, health problems and increased death rates.

"There has been little prior data to describe which caregivers are at greatest risk for distress and which interventions are likely to relieve that distress," said USF nursing professor Susan McMillan, PhD, RN, lead author for the study. "We found that caregivers benefited from even a small number of sessions with the interventionists, above and beyond the benefits gained from hospice care alone."

The Tampa study looked at the effects of a structured psychoeducational intervention for family members caring for terminally ill cancer patients at home. Dr. McMillan, a member of the USF Center for Hospice, Palliative Care and End of Life Studies, worked with a team of researchers at the USF College of Nursing, the USF School of Aging Studies, the USF Division of Geriatric Medicine, the H. Lee Moffitt Cancer Center & Research Institute, and LifePath Hospice and Palliative Care.

In addition to providing standard hospice care, nurses participating in the study taught family caregivers how to better assess and cope with specific cancer symptoms such as pain, constipation and difficulty breathing. The researchers compared this group to caregivers of patients receiving hospice care alone and caregivers of patients receiving hospice care and supportive visits. Dr. McMillan found that with interventions, caregiver quality of life increased while the burden from caregiving, and caregiver distress were significantly reduced.

Family caregivers are central to end-of-life care because they offer emotional support, help with activities of daily living and medications, and communicate with health care professionals about the patient's condition. Yet, caregivers -- many of whom are elderly spouses with their own health problems -- may experience significant strain and anxiety -- from taking care of seriously ill patients, Dr. McMillan said.

"In today's health care system, patients simply don't have the option of being hospitalized for long periods, including at the end of life," she said. "And, most patients tell you they want to be able to die comfortably at home in their own beds. But, that can only happen if we adequately prepare family members to provide extensive care for their loved ones at home."

End-of-life care studies, primarily focused on cancer patients and their caregivers, should be expanded to include other hospice populations, including those with end-stage heart disease, chronic obstructive pulmonary disease and dementia, the researchers recommend.
-end-
Other study researchers were Brent Small, PhD; Michael Weitzner, MD; Ronald Schonwetter, MD; Mary Tittle, PhD; Linda Moody, PhD; and William Haley, PhD.

University of South Florida (USF Health)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.